Odaily Planet Daily reports that NewLimit, the longevity research company co-founded by Coinbase's CEO, has secured $45 million in additional funding from co-founder Jacob Kimmel, who shared a message from NewLimit. Investors include Lilly Ventures, Duke University, S32, and Abstract, with participation from new and existing shareholders such as Kleiner Perkins, Dimension, Human Capital, and Boost VC. This round of funding stems from a technological breakthrough in their project to restore youthful liver function, with plans to initiate clinical studies in the coming years.